HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akira Negi Selected Research

Polypoidal Choroidal Vasculopathy

5/2014LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy.
10/2013Comparison of the effect of ranibizumab and verteporfin for polypoidal choroidal vasculopathy: 12-month LAPTOP study results.
9/2013The association of age-related maculopathy susceptibility 2 (ARMS2) and complement factor H (CFH) variants with two angiographic subtypes of polypoidal choroidal vasculopathy.
5/2013Visual outcome of photodynamic therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy over 5 years of follow-up.
4/2013Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.
1/2012Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy.
9/2011Natural course and funduscopic findings of polypoidal choroidal vasculopathy in a Japanese population over 1 year of follow-up.
4/2011The association of age-related maculopathy susceptibility 2 polymorphisms with phenotype in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
1/2011Early responses to intravitreal ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
8/2009Role of RDBP and SKIV2L variants in the major histocompatibility complex class III region in polypoidal choroidal vasculopathy etiology.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akira Negi Research Topics

Disease

16Macular Degeneration (Age-Related Maculopathy)
01/2017 - 03/2004
15Glaucoma
10/2019 - 03/2003
15Polypoidal Choroidal Vasculopathy
05/2014 - 10/2007
6Ganglion Cysts (Ganglion)
09/2013 - 11/2006
5Low Tension Glaucoma
01/2016 - 10/2008
5Choroidal Neovascularization
01/2014 - 12/2007
3Optic Nerve Injuries
12/2014 - 10/2004
3Retinal Perforations
01/2014 - 11/2004
3Open-Angle Glaucoma (Glaucoma, Open Angle)
06/2011 - 12/2002
3Ocular Hypertension (Glaucoma, Suspect)
01/2006 - 12/2002
2Inflammation (Inflammations)
02/2014 - 01/2008
2Osteoporosis
06/2013 - 01/2010
2Atrophy
10/2012 - 12/2004
2Blister (Bulla)
03/2012 - 04/2008
2Diabetic Retinopathy (Retinopathy, Diabetic)
09/2011 - 09/2008
2Retinal Detachment (Retinal Detachments)
09/2008 - 07/2008
2Endophthalmitis (Ophthalmia)
09/2008 - 12/2007
2Retinopathy of Prematurity (Retrolental Fibroplasia)
07/2008 - 07/2007
2Pupil Disorders (Marcus Gunn Pupil)
05/2007 - 11/2006
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2014
1Central Serous Chorioretinopathy
05/2014
1Wounds and Injuries (Trauma)
01/2014
1Optic Nerve Diseases (Optic Neuropathy)
03/2013
1Optic Atrophy
03/2013
1Hyperoxia
12/2012
1Hemianopsia (Bitemporal Hemianopsia)
10/2012
1Fever (Fevers)
05/2012
1Posterior Uveitis
05/2012
1Vasculitis (Vasculitides)
05/2012
1Eye Diseases (Eye Disease)
01/2012
1Macular Edema
09/2011
1Retinal Vein Occlusion
01/2011
1Starvation
10/2010
1Pathologic Neovascularization
08/2009
1Hypoxia (Hypoxemia)
08/2009
1Retinal Hemorrhage
12/2008
1Familial Exudative Vitreoretinopathies
12/2008
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
09/2008
1Proliferative Vitreoretinopathy
09/2008
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
04/2008

Drug/Important Bio-Agent (IBA)

22Retinaldehyde (Retinal)IBA
09/2013 - 04/2003
61-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2013 - 01/2009
5Ranibizumab (Lucentis)FDA Link
01/2017 - 01/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 03/2005
4Complement Factor H (Factor H)IBA
05/2014 - 02/2009
4Bevacizumab (Avastin)FDA Link
01/2014 - 07/2008
3Diphosphonates (Bisphosphonates)IBA
06/2013 - 12/2007
2Amino Acid Transport System X-AG (Glutamate Transporter)IBA
01/2016 - 03/2011
2Verteporfin (Visudyne)FDA Link
05/2014 - 10/2013
2Aquaporins (Water Channels)IBA
03/2013 - 11/2011
2Oxygen (Dioxygen)IBA
12/2012 - 08/2009
2hydroxide ionIBA
11/2011 - 12/2002
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
09/2011 - 06/2009
2Therapeutic UsesIBA
01/2010 - 04/2009
2LigandsIBA
12/2009 - 10/2008
2Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2009 - 10/2008
2Latanoprost (Xalatan)FDA Link
11/2006 - 12/2002
1Proteins (Proteins, Gene)FDA Link
12/2014
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
05/2014
1Hyaluronic Acid (Hyaluronan)IBA
05/2014
1DNA (Deoxyribonucleic Acid)IBA
05/2014
1Immunoglobulin G (IgG)IBA
02/2014
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2014
1C-Reactive ProteinIBA
05/2012
1Fluorescein (Funduscein)FDA LinkGeneric
05/2012
1Coloring Agents (Dyes)IBA
05/2012
1Protein Kinase CIBA
03/2011
1Dihydrotachysterol (AT 10)IBA
03/2011
1Complement C3 (C3 Complement)IBA
01/2011
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2011
1Small Interfering RNA (siRNA)IBA
10/2010
1HLA-DRB1 Chains (HLA DRB1)IBA
09/2010
1HLA-DQB1 antigen (HLA DQB1)IBA
09/2010
1Complement Factor I (C3b Inactivator)IBA
06/2010
1Toll-Like Receptor 2IBA
12/2009
1Superoxide DismutaseIBA
09/2009
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
08/2009
1Complement C2 (Complement Component 2)IBA
08/2009
1Complement Factor B (Factor B)IBA
08/2009
1RNA-Binding Proteins (RNA-Binding Protein)IBA
08/2009
1pigment epithelium-derived factorIBA
06/2009
1Integrin alphaVbeta3IBA
04/2009
1Peptides (Polypeptides)IBA
04/2009
1BS 1417IBA
04/2009
1Toll-Like Receptor 4IBA
10/2008
1Silicone OilsIBA
09/2008
1ElastinIBA
03/2008

Therapy/Procedure

6Photochemotherapy (Photodynamic Therapy)
10/2013 - 01/2009
5Vitrectomy
01/2014 - 04/2003
4Intravitreal Injections
01/2011 - 04/2008
3Lasers (Laser)
04/2009 - 01/2006
2Therapeutics
03/2012 - 07/2008
2Trabeculectomy (Trabeculoplasty)
03/2012 - 04/2008
1Telescopes
10/2019
1Intracameral Injection
05/2014
1Microspheres (Microsphere)
05/2014
1Aftercare (After-Treatment)
05/2012
1Light Coagulation
07/2008
1Transplantation
04/2008
1Scleral Buckling
01/2008